{"id": "1358215608526114820", "creation": 1612658810.0, "user_id": "1035608508266434564", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Sinovac's #COVID19 #vaccine approved in #China for broad public use. Phase III #clinicaltrials showed varied effective rate in different countries: 50.65% in #Brazil trial, 91.25% in #Turkey trial, and 65.3% in #Indonesia trial #coronavirus @WHO \nhttps://t.co/IZip48Vbii", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#CHINA", "#CLINICALTRIALS", "#BRAZIL", "#TURKEY", "#INDONESIA", "#CORONAVIRUS"]}